Global Cluster Headache
Market Report
2025
As per Cognitive Market Research's latest published report, the Global Cluster Headache market size was $376.11 Million in 2022 and it is forecasted to reach $512.98 million by 2030. Cluster Headache Industry's Compound Annual Growth Rate will be 4.91% from 2023 to 2030.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Cluster Headache Market Report 2025.
As per Cognitive Market Research's latest published report, the Global Cluster Headache market size was $376.11 Million in 2022 and it is forecasted to reach $512.98 million by 2030. Cluster Headache Industry's Compound Annual Growth Rate will be 4.91% from 2023 to 2030.
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Cluster Headache Market Sales Revenue | 121212 | 121212 | 121212 | 4.91% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Drug class |
|
Market Split by Distribution channel |
|
Market Split by Type |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Cluster Headache industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Cluster Headache Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Cluster headaches are the primary headache types known as trigeminal autonomic cephalgia. The cluster headache is a short-lasting unilateral headache with one autonomic symptom ipsilateral to the headache including lacrimation, nasal congestion, conjunctival injection, and aural fullness. This is divided into two types such as episodic cluster headache and chronic cluster headache. In addition, chronic cluster headache attacks continue for longer than 1 year without remission, or remission is less than 2 weeks. Episodic cluster headaches typically last for several weeks and occurrences are separated by a remission period of at least 2 weeks.
Increasing awareness activities related to headache disorders and the development of novel therapeutics for the treatment of cluster headaches are expected to drive the growth of the cluster headache market. In addition, increasing research & development activities for the development of novel drugs is the key factor expected to drive the growth of the cluster headache market.
Increasing investment by the major key players is projected to create growth opportunities for the global cluster headache market in the forecast period.
Side effects of the medications may hamper the growth of the cluster headache market.
We have various report editions of Cluster Headache Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.
The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.
Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.
Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.
Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.
In June 2019, Food and Drug Administration has approved the Emgality solution for injection for the treatment of episodic cluster headaches in adults.
Top Companies Market Share in Cluster Headache Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America has the largest revenue share in the cluster headache market. This is due to the increasing prevalence of cluster headache cases and advanced healthcare infrastructure in the region. In addition, the increasing number of key players offering novel therapeutics is anticipated to drive the growth of the cluster headache market in the region.
The current report Scope analyzes Cluster Headache Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Cluster Headache Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Cluster Headache Industry growth. Cluster Headache market has been segmented with the help of its Drug class, Distribution channel Type, and others. Cluster Headache market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Based on drug class, the triptans segment has the largest revenue share in the cluster headache market. This is attributed to triptans as the first-line treatment for cluster headaches expected to drive the growth of this segment.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Cluster Headache Industry. Request a Free Sample PDF!
Based on the distribution channel, the drug stores and retail pharmacies segment has the largest revenue share in the cluster headache market. This is due to the increasing preference of people toward retail pharmacies and guides regarding medications and usage during the treatment period projected to drive the growth of this segment.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Based on type, the episodic segment has the largest revenue share in the cluster headache market. This is due to the increasing number of people suffering from episodic attacks and regulatory approval of drugs indicated for episodic cluster headaches.
Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Cluster Headache Market is witnessing significant growth in the near future.
In 2023, the Calcium Channel Blockers segment accounted for noticeable share of global Cluster Headache Market and is projected to experience significant growth in the near future.
The Hospitals Clinics segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Drug class | Calcium Channel Blockers, Corticosteroids, Sumatriptan, Lithium Carbonate, Ergots, Melatonin, Anti-seizure, Local Anesthetics |
Distribution channel | Hospitals Clinics, Private Clinics, Retail Pharmacies and Drug Stores, E commerce |
Type | Episodic, Chronic |
List of Competitors | Dr. Reddy’s Laboratories Ltd., FRESENIUS SE & Co. KGaA (Fresenius Kabi), GlaxoSmithKline plc, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Arrotex Australia Group, Grunenthal, Eli Lilly and Company, Novartis AG, Sun Pharmaceutical Industries Ltd. |
This chapter will help you gain GLOBAL Market Analysis of Cluster Headache. Further deep in this chapter, you will be able to review Global Cluster Headache Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Cluster Headache. Further deep in this chapter, you will be able to review North America Cluster Headache Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Cluster Headache. Further deep in this chapter, you will be able to review Europe Cluster Headache Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Cluster Headache. Further deep in this chapter, you will be able to review Asia Pacific Cluster Headache Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Cluster Headache. Further deep in this chapter, you will be able to review South America Cluster Headache Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Cluster Headache. Further deep in this chapter, you will be able to review Middle East Cluster Headache Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Cluster Headache. Further deep in this chapter, you will be able to review Middle East Cluster Headache Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Cluster Headache. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Drug class Analysis 2019 -2031, will provide market size split by Drug class. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Drug class Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Distribution channel Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Type Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Cluster Headache market
Chapter 13 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 14 Research Methodology and Sources
Why Calcium Channel Blockers have a significant impact on Cluster Headache market? |
What are the key factors affecting the Calcium Channel Blockers and Corticosteroids of Cluster Headache Market? |
What is the CAGR/Growth Rate of Hospitals Clinics during the forecast period? |
By type, which segment accounted for largest share of the global Cluster Headache Market? |
Which region is expected to dominate the global Cluster Headache Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|